Morten Frost joined Veracyte in January 2021 and serves as Chief Commercial Officer, In Vitro Diagnostics (IVD). In this role, he leads sales, marketing, and market access for the company’s diagnostics tests, serving physicians and their patients in global markets, as well as Veracyte’s companion diagnostic development services for biopharmaceutical companies. Mr. Frost previously served as Veracyte’s General Manager for Pulmonology & Breast Cancer. Prior to that, he was at Agilent Technologies, where he held several leadership positions across Marketing, Sales and Corporate Development & Strategy. Mr. Frost previously served as a management consultant at IMS Consulting Group (Now IQVIA) where he advised leading pharmaceutical companies on top-line growth and commercial strategy. Mr. Frost sits on the board of Visiopharm, a global digital pathology company with headquarters in Denmark. He holds an MSc in Economics and Business Administration from Copenhagen Business School in Denmark with complementary executive M.B.A. courses from Stanford University.
Chief Commercial Officer, In Vitro Diagnostics (IVD)